A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer (Q33739625)
Jump to navigation
Jump to search
scientific article
Language | Label | Description | Also known as |
---|---|---|---|
English | A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer |
scientific article |
Statements
A phase II study of flavopiridol (Alvocidib) in combination with docetaxel in refractory, metastatic pancreatic cancer (English)
Richard D Carvajal
Archie Tse
Manish A Shah
Robert A Lefkowitz
Mithat Gonen
Lisa Gilman-Rosen
Jeremy Kortmansky
David P Kelsen
Gary K Schwartz
1 reference